Wednesday, July 8, 2009

Prostate Cancer and Comparative Effectiveness

David Leonhardt has an excellent article in this morning's NY Times. It involves prostate cancer and paying for treatment.

Imagine that there is an invasive course of action that is rife with problems. It's more aggressive, but it costs more. It can also lead to horrific side effects. And you do not know if its much better.

That is sort of the state of play in prostate cancer. I think that what Leonhardt is saying is that we will always be making these tough choices. But, if we do not ever make them, then we only end up hurting ourselves.

No comments:

Post a Comment